Skip to main content

Table 1 Demographic and intra-operative characteristics

From: Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study

  Midodrine group Control group p value
N 74 74  
Age 68 [62–75] 65 [58–73.25] 0.184
Male 45 (60.8%) 47 (63.5%) 0.735
Type of surgery    0.220
 Revascularization 38 (51.4%) 33 (44.6%)  
 Valve surgery 17 (23.0%) 19 (25.7%)  
 Combined 16 (21.6%) 22 (29.7%)  
 Other 3 (4.1%) 0 (0%)  
Urgent surgery 15 (20.3%) 10 (13.5%) 0.273
Euroscore II 1.94 [1–2.91] 2.08 [1.31–4.0] 0.088
CPB duration (min) 77 [61–111] 93 [68–120] 0.067
Aortic cross-clamp time (min) 56 [40–82] 69 [40–91] 0.188
PRBC during surgery 0.41 ± 1.33 0.24 ± 0.37 0.21
Fluid balance during surgery (ml) 1037 [318–1850] 951 [595–1605] 0.907
Receiving ACEi or ARB 42 (56.8%) 50 (67.6%) 0.175
  1. ACEi angiotensin conversion enzyme inhibitors, ARB angiotensin receptor blockers, CPB cardiopulmonary bypass, PRBC packed red blood cells